United States · FDA National Drug Code directory
Etoposide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68001-265_30d6f51a-8099-4ff9-9be6-fb0559c88e42
- Product NDC
- 68001-265
- Form
- INJECTION
- Composition / generic term
- Etoposide
- Labeler
- BluePoint Laboratories
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20131114
- Source listing expiry
- 20261231
Source-listed ingredients
- ETOPOSIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 BOX (68001-265-25) / 5 mL in 1 VIAL, MULTI-DOSE (68001-265-22) · 68001-265-25
- 1 VIAL, MULTI-DOSE in 1 BOX (68001-265-26) / 25 mL in 1 VIAL, MULTI-DOSE (68001-265-23) · 68001-265-26
- 1 VIAL, MULTI-DOSE in 1 BOX (68001-265-27) / 50 mL in 1 VIAL, MULTI-DOSE (68001-265-24) · 68001-265-27
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →